VTR
46
-3
CB
44
-3
FSLR
57
8
BA
53
5
SEE
49
3
UA
36
-5
PNW
60
-6
CRM
59
2
TMO
51
4
RF
56
-2
HRL
30
-6
KIM
66
2
UNH
55
2
M
28
-3
TDC
75
12
EMN
52
-4
TXN
48
3
LH
40
-2
VMC
62
-7
CMG
63
9
VTR
46
-3
CB
44
-3
FSLR
57
8
BA
53
5
SEE
49
3
UA
36
-5
PNW
60
-6
CRM
59
2
TMO
51
4
RF
56
-2
HRL
30
-6
KIM
66
2
UNH
55
2
M
28
-3
TDC
75
12
EMN
52
-4
TXN
48
3
LH
40
-2
VMC
62
-7
CMG
63
9
Financhill
Back

LENZ Therapeutics Quote, Financials, Valuation and Earnings

U.S. Government Report Alert Tuesday

Discover the Secret Loophole
Sell
49

LENZ
LENZ Therapeutics

Last Price:
28.32
Seasonality Move:
-18.63%

7 Day Trial

ALL ACCESS PASS

$ 7

Write This Down: Tuesday at 2 p.m. ET!

Don't Miss Our LIVE Trade

LENZ Therapeutics Price Quote

$28.32
-0.11 (1.4%)
(Updated: November 5, 2024 at 2:52 AM ET)

LENZ Therapeutics Key Stats

Sell
49
LENZ Therapeutics (LENZ) is a Sell
Day range:
$27.36 - $29.00
52-week range:
$14.07 - $31.00
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
0.00
P/B ratio:
4.05%
Volume:
136.9K
Avg. volume:
165K
1-year change:
76.58%
Market cap:
$781M
Revenue:
$15M
EPS:
$-5.6

How Much Does LENZ Therapeutics Make?

Data Unavailable

Is LENZ Therapeutics Growing As A Company?

Data Unavailable

LENZ Therapeutics Stock Price Performance

What Is LENZ Therapeutics 52-Week High & Low?

LENZ Therapeutics Price To Free Cash Flow

Data Unavailable

Is It Risky To Buy LENZ Therapeutics?

  • How Much Debt Does LENZ Therapeutics Have?
    Total long term debt quarterly is $0
  • How Much Cash Does LENZ Therapeutics Have?
    Cash and short term investments quarterly total is $196.1M
  • What Is LENZ Therapeutics’s Book Value Per Share?
    Book value per share is 7.46

Is LENZ Therapeutics Cash Flow Positive?

  • What Is LENZ Cash Flow From Operations?
    Cash flow from operations (TTM) is -$73.8M
  • What Is LENZ Therapeutics’s Cash Flow From Financing?
    Cash flow from financing (TTM) is $166.7M
  • What Is LENZ Therapeutics’s Cash Flow From Investing?
    Cash flow from investing (TTM) is -$83.1M

LENZ Therapeutics Return On Invested Capital

Data Unavailable

LENZ Therapeutics Earnings Date & Stock Price

LENZ Therapeutics Competitors

  • Who Are LENZ Therapeutics's Competitors?
    Below is a list of companies who compete with LENZ Therapeutics or are related in some way:
    • Oruka Therapeutics Inc (ORKA)
    • PetMed Express Inc (PETS)
    • R1 RCM Inc (RCM)
    • Streamline Health Solutions Inc (STRM)
    • TruBridge Inc (TBRG)

LENZ Therapeutics Dividend Yield

LENZ Therapeutics Analyst Estimates

YoY Growth Past Surprise
EPS: 0% 40.3%
Revenue: 0% 0%

Analyst Recommendations

Buy Recommendations: 4
Hold Recommendations: 0
Sell Recommendations: 0
Price Target: 35.57
Upside from Last Price: 25.12%

Major Shareholders

  • How many LENZ shares are owned by institutional investors?
    29.6M LENZ shares are owned by institutional investors
  • How many LENZ shares are owned by insiders?
    242.8K LENZ shares are owned by insiders